Analog Devices (ADI) 10-Q 18 Aug 21 2021 Q3 Quarterly report Financial data

Cover

Cover	9 Months Ended
	Jul. 31, 2021shares
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Jul. 31, 2021
Document Transition Report	false
Entity File Number	1-7819
Entity Registrant Name	Analog Devices, Inc.
Entity Incorporation, State or Country Code	MA
Entity Tax Identification Number	04-2348234
Entity Address, Address Line One	One Analog Way,
Entity Address, City or Town	Wilmington,
Entity Address, State or Province	MA
Entity Address, Postal Zip Code	01887
City Area Code	781
Local Phone Number	329-4700
Title of 12(b) Security	Common Stock $0.16 2/3 par value per share
Entity Trading Symbol	ADI
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding	368,214,341
Entity Central Index Key	0000006281
Current Fiscal Year End Date	--10-30
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	Q3
Amendment Flag	false

Condensed Consolidated Statemen

Condensed Consolidated Statements of Income - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Jul. 31, 2021	Aug. 01, 2020	Jul. 31, 2021	Aug. 01, 2020
Income Statement [Abstract]
Revenue	$ 1,758,853	$ 1,456,136	$ 4,978,718	$ 4,076,761
Cost of sales	537,669	483,558	1,575,526	1,409,367
Gross margin	1,221,184	972,578	3,403,192	2,667,394
Operating expenses:
Research and development	306,617	260,794	897,005	770,280
Selling, marketing, general and administrative	206,076	153,753	597,963	494,808
Amortization of intangibles	107,783	107,077	323,217	321,448
Special charges, net	(8,938)	31,830	(8,189)	44,286
Total operating expenses	611,538	553,454	1,809,996	1,630,822
Operating income:	609,646	419,124	1,593,196	1,036,572
Nonoperating expense (income):
Interest expense	44,659	45,914	130,204	144,712
Interest income	(300)	(504)	(799)	(3,778)
Other, net	(6,991)	685	(21,090)	1,331
Nonoperating expense (income)	37,368	46,095	108,315	142,265
Income before income taxes	572,278	373,029	1,484,881	894,307
Provision for income taxes	68,967	10,364	170,146	60,072
Net income	$ 503,311	$ 362,665	$ 1,314,735	$ 834,235
Shares used to compute earnings per common share – basic (in shares)	368,476	368,791	368,834	368,417
Shares used to compute earnings per common share – diluted (in shares)	371,849	372,003	372,457	371,857
Basic earnings per common share (in dollars per share)	$ 1.37	$ 0.98	$ 3.56	$ 2.26
Diluted earnings per common share (in dollars per share)	$ 1.35	$ 0.97	$ 3.53	$ 2.24

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Income - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jul. 31, 2021	Aug. 01, 2020	Jul. 31, 2021	Aug. 01, 2020
Statement of Comprehensive Income [Abstract]
Net income	$ 503,311	$ 362,665	$ 1,314,735	$ 834,235
Foreign currency translation adjustments	(2,952)	7,257	5,073	197
Change in fair value of derivative instruments designated as cash flow hedges (net of taxes of $10,657, $1,437, $6,452 and $26,503, respectively)	(40,040)	(1,605)	19,853	(83,016)
Changes in pension plans, net actuarial loss and foreign currency translation adjustments (net of taxes of $85, $168, $257 and $485, respectively)	964	(1,579)	(408)	68
Other comprehensive (loss) income	(42,028)	4,073	24,518	(82,751)
Comprehensive income	$ 461,283	$ 366,738	$ 1,339,253	$ 751,484

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Comprehensive Income (Parenthetical) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jul. 31, 2021	Aug. 01, 2020	Jul. 31, 2021	Aug. 01, 2020
Statement of Comprehensive Income [Abstract]
Tax effect of change in fair value of derivative instruments designated as cash flow hedges	$ 10,657	$ 1,437	$ (6,452)	$ 26,503
Tax effect of changes in pension plans, net actuarial loss and foreign currency translation adjustments	$ (85)	$ 168	$ (257)	$ (485)

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Jul. 31, 2021	Oct. 31, 2020
Current Assets
Cash and cash equivalents	$ 1,480,701	$ 1,055,860
Accounts receivable	823,163	737,536
Inventories	657,520	608,260
Prepaid expenses and other current assets	129,071	116,032
Total current assets	3,090,455	2,517,688
Property, Plant and Equipment, at Cost
Land and buildings	954,125	974,604
Machinery and equipment	2,825,698	2,667,846
Office equipment	89,399	85,291
Leasehold improvements	160,983	157,915
Gross property, plant, and equipment	4,030,205	3,885,656
Less accumulated depreciation and amortization	2,856,531	2,765,095
Net property, plant and equipment	1,173,674	1,120,561
Other Assets
Other investments	105,562	86,729
Goodwill	12,278,898	12,278,425
Intangible assets, net	3,248,802	3,650,280
Deferred tax assets	1,425,293	1,503,064
Other assets	318,506	311,856
Total other assets	17,377,061	17,830,354
Total assets	21,641,190	21,468,603
Current Liabilities
Accounts payable	265,933	227,273
Income taxes payable	233,055	182,080
Debt, current	1,324,677	0
Accrued liabilities	969,677	955,633
Total current liabilities	2,793,342	1,364,986
Non-current liabilities
Long-term debt	3,824,819	5,145,102
Deferred income taxes	1,776,308	1,919,595
Income taxes payable	529,057	591,780
Other non-current liabilities	453,701	449,195
Total non-current liabilities	6,583,885	8,105,672
Commitments and contingencies	0	0
Shareholders’ Equity
Preferred stock, $1.00 par value, 471,934 shares authorized, none outstanding	0	0
Common stock, 0.16 2/3 par value, 1,200,000,000 shares authorized, 368,214,341 shares outstanding (369,484,899 on October 31, 2020)	61,370	61,582
Capital in excess of par value	4,614,677	4,949,586
Retained earnings	7,812,859	7,236,238
Accumulated other comprehensive loss	(224,943)	(249,461)
Total shareholders’ equity	12,263,963	11,997,945
Liabilities and Shareholders' Equity	$ 21,641,190	$ 21,468,603

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Jul. 31, 2021	Oct. 31, 2020
Statement of Financial Position [Abstract]
Preferred stock, par value (in dollars per share)	$ 1	$ 1
Preferred stock, shares authorized (in shares)	471,934	471,934
Preferred stock, shares outstanding (in shares)	0	0
Common stock, par value (in dollars per share)	$ 0.16	$ 0.16
Common stock, shares authorized (in shares)	1,200,000,000	1,200,000,000
Common stock, shares outstanding (in shares)	368,214,341	369,484,899

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Shareholders' Equity - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock	Capital in Excess of Par Value	Retained Earnings	Retained EarningsCumulative effect, period of adoption, adjustment	Accumulated Other Comprehensive Loss	Accumulated Other Comprehensive LossCumulative effect, period of adoption, adjustment
Beginning balance (in shares) at Nov. 02, 2019		368,302
Beginning balance at Nov. 02, 2019		$ 61,385	$ 4,936,349	$ 6,899,253	$ 2,379	$ (187,799)	$ (2,379)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	$ 834,235			834,235
Dividends declared and paid				(656,558)
Issuance of stock as charitable contribution (in shares)		336
Issuance of stock as charitable contribution		$ 56	39,944
Issuance of stock under stock plans and other (in shares)		2,730
Issuance of stock under stock plans and other		$ 455	57,295
Stock-based compensation expense			112,961
Other comprehensive income (loss)	(82,751)					(82,751)
Common stock repurchased (in shares)		(2,202)
Common stock repurchased		$ (367)	(236,898)
Ending balance (in shares) at Aug. 01, 2020		369,166
Ending balance at Aug. 01, 2020		$ 61,529	4,909,651	7,079,309		(272,929)
Beginning balance (in shares) at May. 02, 2020		368,425
Beginning balance at May. 02, 2020		$ 61,405	4,861,013	6,945,442		(277,002)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	362,665			362,665
Dividends declared and paid				(228,798)
Issuance of stock under stock plans and other (in shares)		892
Issuance of stock under stock plans and other		$ 149	26,704
Stock-based compensation expense			39,560
Other comprehensive income (loss)	4,073					4,073
Common stock repurchased (in shares)		(151)
Common stock repurchased		$ (25)	(17,626)
Ending balance (in shares) at Aug. 01, 2020		369,166
Ending balance at Aug. 01, 2020		$ 61,529	4,909,651	7,079,309		(272,929)
Beginning balance (in shares) at Oct. 31, 2020		369,485
Beginning balance at Oct. 31, 2020	11,997,945	$ 61,582	4,949,586	7,236,238		(249,461)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	1,314,735			1,314,735
Dividends declared and paid				(738,114)
Issuance of stock under stock plans and other (in shares)		2,040
Issuance of stock under stock plans and other		$ 340	55,008
Stock-based compensation expense			118,683
Other comprehensive income (loss)	24,518					24,518
Common stock repurchased (in shares)		(3,311)
Common stock repurchased		$ (552)	(508,600)
Ending balance (in shares) at Jul. 31, 2021		368,214
Ending balance at Jul. 31, 2021	12,263,963	$ 61,370	4,614,677	7,812,859		(224,943)
Beginning balance (in shares) at May. 01, 2021		368,827
Beginning balance at May. 01, 2021		$ 61,472	4,724,493	7,564,054		(182,915)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	503,311			503,311
Dividends declared and paid				(254,506)
Issuance of stock under stock plans and other (in shares)		396
Issuance of stock under stock plans and other		$ 66	11,610
Stock-based compensation expense			41,687
Other comprehensive income (loss)	(42,028)					(42,028)
Common stock repurchased (in shares)		(1,009)
Common stock repurchased		$ (168)	(163,113)
Ending balance (in shares) at Jul. 31, 2021		368,214
Ending balance at Jul. 31, 2021	$ 12,263,963	$ 61,370	$ 4,614,677	$ 7,812,859		$ (224,943)

Condensed Consolidated Statem_5

Condensed Consolidated Statements of Shareholders' Equity (Parenthetical) - $ / shares	3 Months Ended		9 Months Ended
	Jul. 31, 2021	Aug. 01, 2020	Jul. 31, 2021	Aug. 01, 2020
Statement of Stockholders' Equity [Abstract]
Dividends (in dollars per share)	$ 0.69	$ 0.62	$ 2	$ 1.78

Condensed Consolidated Statem_6

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Jul. 31, 2021	Aug. 01, 2020
Cash flows from operating activities:
Net income	$ 1,314,735	$ 834,235
Adjustments to reconcile net income to net cash provided by operations:
Depreciation	158,937	176,722
Amortization of intangibles	436,734	431,985
Stock-based compensation expense	118,683	112,961
Gain on sale of property, plant and equipment	(13,557)	0
Deferred income taxes	(72,578)	(42,802)
Non-cash contribution to charitable foundation	0	40,000
Other	(14,965)	5,675
Changes in operating assets and liabilities	(133,644)	(222,887)
Total adjustments	479,610	501,654
Net cash provided by operating activities	1,794,345	1,335,889
Cash flows from investing activities:
Proceeds from other investments	22,215	0
Additions to property, plant and equipment	(212,899)	(135,804)
Proceeds from sale of property, plant and equipment	35,714	0
Payments for acquisitions, net of cash acquired	(24,950)	(12,763)
Changes in other assets	(3,360)	(1,214)
Net cash used for investing activities	(183,280)	(149,781)
Cash flows from financing activities:
Proceeds from debt	0	395,646
Proceeds from revolver	0	350,000
Payments on revolver	0	(350,000)
Debt repayments	0	(300,000)
Dividend payments to shareholders	(738,114)	(656,558)
Repurchase of common stock	(509,152)	(237,265)
Proceeds from employee stock plans	55,348	57,750
Changes in other financing activities	1,952	(4,015)
Net cash used for financing activities	(1,189,966)	(744,442)
Effect of exchange rate changes on cash	3,742	276
Net increase in cash and cash equivalents	424,841	441,942
Cash and cash equivalents at beginning of period	1,055,860	648,322
Cash and cash equivalents at end of period	$ 1,480,701	$ 1,090,264

Basis of Presentation

Basis of Presentation	9 Months Ended
	Jul. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation	Basis of Presentation In the opinion of management, the information furnished in the accompanying condensed consolidated financial statements reflects all normal recurring adjustments that are necessary to fairly state the results for these interim periods and should be read in conjunction with Analog Devices, Inc.’s (the Company) Annual Report on Form 10-K for the fiscal year ended October 31, 2020 (fiscal 2020) and related notes. The results of operations for the interim periods shown in this report are not necessarily indicative of the results that may be expected for the fiscal year ending October 30, 2021 (fiscal 2021) or any future period. The Company has a 52-53 week fiscal year that ends on the Saturday closest to the last day in October. Certain amounts reported in previous periods have been reclassified to conform to the fiscal 2021 presentation. Proposed acquisition of Maxim Integrated Products, Inc. On July 12, 2020, the Company entered into a definitive agreement (the Merger Agreement) to acquire Maxim Integrated Products, Inc. (Maxim), an independent manufacturer of innovative analog and mixed-signal products and technologies. See Note 14, Acquisitions , for additional information.

Stock-Based Compensation and Sh

Stock-Based Compensation and Shareholders' Equity	9 Months Ended
	Jul. 31, 2021
Share-based Payment Arrangement [Abstract]
Stock-Based Compensation and Shareholders' Equity	Stock-Based Compensation and Shareholders' Equity A summary of the Company’s stock option activity as of July 31, 2021 and changes during the nine-month period then ended is presented below: Options Outstanding (in thousands) Weighted- Average Exercise Price Per Share Weighted- Average Remaining Contractual Term in Years Aggregate Intrinsic Value Options outstanding at October 31, 2020 4,192 $70.73 Options granted 644 $145.04 Options exercised (875) $63.18 Options forfeited (36) $87.18 Options expired (6) $40.69 Options outstanding at July 31, 2021 3,919 $84.53 5.7 $324,862 Options exercisable at July 31, 2021 2,511 $66.15 4.3 $254,262 Options vested or expected to vest at July 31, 2021 (1) 3,816 $83.41 5.7 $320,532 (1) In addition to the vested options, the Company expects a portion of the unvested options to vest at some point in the future. The number of options expected to vest is calculated by applying an estimated forfeiture rate to the unvested options. In the first quarter of fiscal 2021, the Company issued a special performance stock option award to the Company's chief executive officer. The performance stock option award is exercisable for up to 460,000 shares of the Company's common stock (the Target Number of Shares) at an exercise price per share of $144.06, which was the closing price of the Company's common stock on the date of grant, and vests subject to the satisfaction of certain target stock price thresholds during a five-year period, measured on the basis of the average of the closing prices of the Company's common stock over 70 consecutive trading days. The actual number of shares that will become exercisable will range from 0% to a maximum of 100% of the Target Number of Shares based on the attainment of such target stock price thresholds at any time during a five-year period from December 15, 2020 to December 15, 2025. The grant date fair value of the award was calculated using the Monte Carlo simulation model which utilizes multiple input variables that determine the probability of satisfying the performance conditions stipulated in the award to calculate the fair market value. The Monte Carlo simulation model also uses stock price volatility and other variables to estimate the probability of satisfying the performance conditions, including the possibility that the market condition may not be satisfied, and the resulting fair value of the award. During the nine-month periods ended July 31, 2021 and August 1, 2020, the total intrinsic value of options exercised (i.e., the difference between the market price at exercise and the price paid by the employee to exercise the options) was $79.1 million and $61.7 million, respectively. A summary of the Company’s restricted stock unit/award activity as of July 31, 2021 and changes during the nine-month period then ended is presented below: Restricted Stock Units/Awards Outstanding (in thousands) Weighted- Average Grant- Date Fair Value Per Share Restricted stock units/awards outstanding at October 31, 2020 3,637 $91.54 Units/Awards granted 1,034 $143.88 Restrictions lapsed (1,160) $89.08 Forfeited (163) $100.74 Restricted stock units/awards outstanding at July 31, 2021 3,348 $107.70 In the first half of fiscal 2021, the Company issued approximately 121,000 performance-based restricted stock units (Maxim Integration PRSUs) related to the Company's planned acquisition of Maxim to a select group of employees. The number of Maxim Integration PRSUs that may be earned will range from 0% to a maximum of 200% of the issued amount of Maxim Integration PRSUs and will be determined according to the achievement of certain performance metrics. Any shares earned will vest on the 60th day following the two-year anniversary of the closing of the Maxim acquisition. If the Maxim acquisition does not close, the awards will be cancelled. The grant date fair value of these awards were calculated using the value of the Company's common stock on the date of grant, reduced by the present value of dividends expected to be paid on the Company's common stock prior to vesting. The grant-date fair value of these awards is also impacted by the number of units that are expected to vest during the performance period and is adjusted through the related stock-based compensation expense at each reporting period based on the probability of achievement of that performance condition. As of July 31, 2021, there was $337.9 million of total unrecognized compensation cost related to unvested stock-based awards comprised of stock options and restricted stock units/awards. That cost is expected to be recognized over a weighted-average period of 1.4 years. The total grant-date fair values of awards that vested during the nine-month periods ended July 31, 2021 and August 1, 2020 were approximately $114.7 million and $157.9 million, respectively. Total stock-based compensation expense recognized was as follows: Three Months Ended Nine Months Ended July 31, 2021 August 1, 2020 July 31, 2021 August 1, 2020 Cost of sales $ 4,331 $ 4,508 $ 13,338 $ 13,428 Research and development 19,806 19,158 57,675 55,163 Selling, marketing, general and administrative 17,550 14,951 47,670 43,427 Special charges, net — 943 — 943 Total stock-based compensation expense $ 41,687 $ 39,560 $ 118,683 $ 112,961 As of July 31, 2021 and October 31, 2020, the Company capitalized $6.0 million and $5.8 million, respectively, of stock-based compensation in Inventories on the Condensed Consolidated Balance Sheets. Common Stock Repurchases As of July 31, 2021, the Company had repurchased a total of approximately 159.0 million shares of its common stock for approximately $6.7 billion under the Company's share repurchase program. As of July 31, 2021, an additional $1.4 billion remains available for repurchase of shares under the current authorized program. The Company also repurchases shares in settlement of employee tax withholding obligations due upon the vesting of restricted stock units/awards or the exercise of stock options. Future repurchases of common stock will be dependent upon the Company's financial position, results of operations, outlook, liquidity, and other factors deemed relevant by the Company.

Accumulated Other Comprehensive

Accumulated Other Comprehensive (Loss) Income	9 Months Ended
	Jul. 31, 2021
Equity [Abstract]
Accumulated Other Comprehensive (Loss) Income	Accumulated Other Comprehensive (Loss) Income The following table provides the changes in accumulated other comprehensive (loss) income (AOCI) by component and the related tax effects during the first nine months of fiscal 2021. Foreign currency translation adjustment Unrealized holding gains (losses) on derivatives Pension plans Total October 31, 2020 $ (26,852) $ (172,670) $ (49,939) $ (249,461) Other comprehensive income (loss) before reclassifications 5,073 32,548 (2,396) 35,225 Amounts reclassified out of other comprehensive income (loss) — (6,243) 2,245 (3,998) Tax effects — (6,452) (257) (6,709) Other comprehensive income (loss) 5,073 19,853 (408) 24,518 July 31, 2021 $ (21,779) $ (152,817) $ (50,347) $ (224,943) The amounts reclassified out of AOCI into the Condensed Consolidated Statements of Income and the Condensed Consolidated Statements of Shareholders' Equity with presentation location during each period were as follows: Three Months Ended Nine Months Ended Comprehensive Income Component July 31, 2021 August 1, 2020 July 31, 2021 August 1, 2020 Location Unrealized holding losses (gains) on derivatives Currency forwards $ (351) $ (842) $ (3,700) $ (762) Cost of sales (283) (226) (2,138) 640 Research and development 28 (189) (1,796) 895 Selling, marketing, general and administrative Interest rate derivatives 464 464 1,391 1,392 Interest expense (142) (793) (6,243) 2,165 Total before tax (28) 79 505 (488) Tax Effect of Accounting Standards Update 2018-02 — — — (2,379) Retained earnings $ (170) $ (714) $ (5,738) $ (702) Net of tax Amortization of pension components included in the computation of net periodic pension cost Actuarial losses 747 672 2,245 1,954 (85) (168) (257) (485) Tax $ 662 $ 504 $ 1,988 $ 1,469 Net of tax Total amounts reclassified out of AOCI, net of tax $ 492 $ (210) $ (3,750) $ 767 Realized gains or losses on investments are determined based on the specific identification basis and are recognized in nonoperating expense (income). There were no material net realized gains or losses from the sales of available-for-sale investments during any of the fiscal periods presented.

Earnings Per Share

Earnings Per Share	9 Months Ended
	Jul. 31, 2021
Earnings Per Share [Abstract]
Earnings Per Share	Earnings Per Share The following table sets forth the computation of basic and diluted earnings per share: Three Months Ended Nine Months Ended July 31, 2021 August 1, 2020 July 31, 2021 August 1, 2020 Net Income $ 503,311 $ 362,665 $ 1,314,735 $ 834,235 Basic shares: Weighted-average shares outstanding 368,476 368,791 368,834 368,417 Earnings per common share basic: $ 1.37 $ 0.98 $ 3.56 $ 2.26 Diluted shares: Weighted-average shares outstanding 368,476 368,791 368,834 368,417 Assumed exercise of common stock equivalents 3,373 3,212 3,623 3,440 Weighted-average common and common equivalent shares 371,849 372,003 372,457 371,857 Earnings per common share diluted: $ 1.35 $ 0.97 $ 3.53 $ 2.24 Anti-dilutive shares related to: Outstanding stock-based awards 645 384 502 487

Special Charges, net

Special Charges, net	9 Months Ended
	Jul. 31, 2021
Restructuring and Related Activities [Abstract]
Special Charges, net	Special Charges, net The following table is a quarterly roll-forward from October 31, 2020 to July 31, 2021 of the employee separation and exit cost accruals established related to existing restructuring actions: Accrued Restructuring Closure of Manufacturing Facilities Repositioning Action Other Actions Balance at October 31, 2020 $ 45,176 $ 20,774 $ 3,489 First quarter fiscal 2021 special charges 438 — — Severance and other payments (1,950) (8,128) (333) Effect of foreign currency on accrual — 248 — Balance at January 30, 2021 $ 43,664 $ 12,894 $ 3,156 Second quarter fiscal 2021 special charges 311 — — Severance and other payments (5,769) (2,767) (270) Effect of foreign currency on accrual — (44) — Balance at May 1, 2021 $ 38,206 $ 10,083 $ 2,886 Third quarter fiscal 2021 special charges 4,618 — — Severance and other payments (15,949) (2,178) (219) Effect of foreign currency on accrual — (24) — Balance at July 31, 2021 $ 26,875 $ 7,881 $ 2,667 Accrued liabilities $ 26,875 $ 7,881 $ 2,667 Special charges, net, for the quarter ended July 31, 2021 was a net gain of $8.9 million, which included charges of $4.6 million related to the closure of the Company’s manufacturing facilities reflected in the table above as well as a gain of $13.6 million related to the sale of the Company’s Singapore test facility described further below. Repositioning Action The Company recorded special charges of $137.5 million on a cumulative basis through July 31, 2021, as a result of organizational initiatives to better align the global workforce with the Company's long-term strategic plan. Approximately $123.3 million of the total charges was for severance and fringe benefit costs in accordance with either the Company's ongoing benefit plan or statutory requirements for the impacted manufacturing, engineering and selling, marketing, general and administrative (SMG&A) employees. The remaining $14.2 million of the charges were recorded in the fiscal year ended November 2, 2019 (fiscal 2019) and related to the write-off of acquired intellectual property due to the Company's decision to discontinue certain product development strategies. Closure of Manufacturing Facilities The Company recorded net special charges of $46.8 million on a cumulative basis through July 31, 2021 as a result of its decision to consolidate certain wafer and test facility operations acquired as part of the acquisition of Linear Technology Corporation (Linear). The special charges include severance and fringe benefit costs, in accordance with the Company's ongoing benefit plan or statutory requirements at foreign locations, one-time termination benefits for the impacted manufacturing, engineering and SMG&A employees and other exit costs. These one-time termination benefits are being recognized over the future service period required for employees to earn these benefits. During the third quarter of fiscal 2021, the Company ceased production at its Hillview wafer fabrication facility located in Milpitas, California and determined that this facility met the held for sale criteria specified in Accounting Standards Codification (ASC ) 360. See Note 6 - Property, Plant and Equipment for amounts reclassified.

Property, Plant and Equipment

Property, Plant and Equipment	9 Months Ended
	Jul. 31, 2021
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment	Property, Plant and Equipment During the third quarter of fiscal 2021, the Company ceased production at its Hillview wafer fabrication facility located in Milpitas, California and determined that this facility met the held for sale criteria specified in ASC 360. No write-down to fair value was required upon this designation, as the fair value of the asset group, less costs to sell, was greater than its carrying value. As shown below, this carrying value was reclassified from Property, plant and equipment to Prepaid expenses and other current assets upon designation and remains in Prepaid expenses and other current assets as of July 31, 2021. Land and buildings $ 42,608 Less accumulated depreciation and amortization (13,634) Net property, plant and equipment reclassified to Prepaid expenses and other current assets $ 28,974

Segment Information

Segment Information	9 Months Ended
	Jul. 31, 2021
Segment Reporting [Abstract]
Segment Information	Segment Information The Company designs, develops, manufactures and markets a broad range of integrated circuits. The Company operates and tracks its results in one reportable segment based on the aggregation of nine operating segments. Revenue Trends by End Market The following table summarizes revenue by end market. The categorization of revenue by end market is determined using a variety of data points including the technical characteristics of the product, the “sold to” customer information, the “ship to” customer information and the end customer product or application into which the Company’s product will be incorporated. As data systems for capturing and tracking this data and the Company's methodology evolves and improves, the categorization of products by end market can vary over time. When this occurs, the Company reclassifies revenue by end market for prior periods. Such reclassifications typically do not materially change the sizing of, or the underlying trends of results within, each end market. Three Months Ended July 31, 2021 August 1, 2020 Revenue % of Revenue* Y/Y% Revenue % of Revenue* Industrial $ 1,001,867 57 % 29 % $ 778,361 53 % Communications 288,743 16 % (21) % 363,304 25 % Automotive 290,077 16 % 80 % 161,489 11 % Consumer 178,166 10 % 16 % 152,982 11 % Total revenue $ 1,758,853 100 % 21 % $ 1,456,136 100 % Nine Months Ended July 31, 2021 August 1, 2020 Revenue % of Revenue* Y/Y% Revenue % of Revenue* Industrial $ 2,829,648 57 % 30 % $ 2,184,413 54 % Communications 847,632 17 % (4) % 880,633 22 % Automotive 793,443 16 % 45 % 548,002 13 % Consumer 507,995 10 % 10 % 463,713 11 % Total revenue $ 4,978,718 100 % 22 % $ 4,076,761 100 % * The sum of the individual percentages may not equal the total due to rounding. Revenue by Sales Channel The following table summarizes revenue by channel. The Company sells its products globally through a direct sales force, third party distributors, independent sales representatives and via its website. Distributors are customers that buy products with the intention of reselling them. Direct customers are non-distributor customers and consist primarily of original equipment manufacturers (OEMs). Other customers include the U.S. government, government prime contractors and certain commercial customers for which revenue is recorded over time. Three Months Ended July 31, 2021 August 1, 2020 Channel Revenue % of Revenue* Revenue % of Revenue* Distributors $ 1,123,301 64 % $ 819,472 56 % Direct customers 588,001 33 % 614,770 42 % Other 47,551 3 % 21,894 2 % Total revenue $ 1,758,853 100 % $ 1,456,136 100 % Nine Months Ended July 31, 2021 August 1, 2020 Channel Revenue % of Revenue* Revenue % of Revenue* Distributors $ 3,162,615 64 % $ 2,317,421 57 % Direct customers 1,724,012 35 % 1,692,152 42 % Other 92,091 2 % 67,188 2 % Total revenue $ 4,978,718 100 % $ 4,076,761 100 % * The sum of the individual percentages may not equal the total due to rounding.

Fair Value

Fair Value	9 Months Ended
	Jul. 31, 2021
Fair Value Disclosures [Abstract]
Fair Value	Fair Value The Company defines fair value as the price that would be received to sell an asset or be paid to transfer a liability in an orderly transaction between market participants at the measurement date. The Company applies the following fair value hierarchy, which prioritizes the inputs used to measure fair value into three levels and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). Level 1 — Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date. Level 2 — Level 2 inputs are inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly. If the asset or liability has a specified (contractual) term, a Level 2 input must be observable for substantially the full term of the asset or liability. Level 3 — Level 3 inputs are unobservable inputs for the asset or liability in which there is little, if any, market activity for the asset or liability at the measurement date. The tables below, set forth by level, presents the Company’s financial assets and liabilities, excluding accrued interest components that were accounted for at fair value on a recurring basis as of July 31, 2021 and October 31, 2020. The tables exclude cash on hand and assets and liabilities that are measured at historical cost or any basis other than fair value. As of July 31, 2021 and October 31, 2020, the Company held $289.7 million and $239.6 million, respectively, of cash that was excluded from the tables below. July 31, 2021 Fair Value measurement at Reporting Date using: Quoted Prices in Active Markets for Identical Assets (Level 1) Significant Other Observable Inputs (Level 2) Total Assets Cash equivalents: Available-for-sale: Government and institutional money market funds $ 810,935 $ — $ 810,935 Corporate obligations (1) — 380,050 380,050 Other assets: Deferred compensation plan investments 68,383 — 68,383 Total assets measured at fair value $ 879,318 $ 380,050 $ 1,259,368 Liabilities Forward foreign currency exchange contracts (2) $ — $ 4,573 $ 4,573 Interest rate derivatives — 181,189 181,189 Total liabilities measured at fair value $ — $ 185,762 $ 185,762 (1) The amortized cost of the Company’s investments classified as available-for-sale as of July 31, 2021 was $380.0 million. (2) The Company has master netting arrangements by counterparty with respect to derivative contracts. See Note 9, Derivatives, in these Notes to Condensed Consolidated Financial Statements for more information related to the Company's master netting arrangements. October 31, 2020 Fair Value measurement at Reporting Date using: Quoted Prices in Active Markets for Identical Assets (Level 1) Significant Other Observable Inputs (Level 2) Total Assets Cash equivalents: Available-for-sale: Government and institutional money market funds $ 816,253 $ — $ 816,253 Other assets: Forward foreign currency exchange contracts (1) — 5,427 5,427 Deferred compensation plan investments 52,956 — 52,956 Total assets measured at fair value $ 869,209 $ 5,427 $ 874,636 Liabilities Interest rate derivatives $ — $ 214,586 $ 214,586 Total liabilities measured at fair value $ — $ 214,586 $ 214,586 (1) The Company has master netting arrangements by counterparty with respect to derivative contracts. See Note 9, Derivatives, in these Notes to Condensed Consolidated Financial Statements for more information related to the Company's master netting arrangements. The following methods and assumptions were used by the Company in estimating its fair value disclosures for financial instruments: Cash equivalents — These investments are adjusted to fair value based on quoted market prices or are determined using a yield curve model based on current market rates. Deferred compensation plan investments — The fair value of these mutual fund, money market fund and equity investments are based on quoted market prices. Interest rate derivatives — The fair value of the interest rate derivatives is estimated using a discounted cash flow analysis based on the contractual terms of the derivative. Forward foreign currency exchange contracts — The estimated fair value of forward foreign currency exchange contracts, which includes derivatives that are accounted for as cash flow hedges and those that are not designated as cash flow hedges, is based on the estimated amount the Company would receive if it sold these agreements at the reporting date taking into consideration current interest rates as well as the creditworthiness of the counterparty for assets and the Company’s creditworthiness for liabilities. The fair value of these instruments is based upon valuation models using current market information such as strike price, spot rate, maturity date and volatility. Financial Instruments Not Recorded at Fair Value on a Recurring Basis Held for sale assets — The Company has classified the assets held for sale at carrying value. However, if they were to be carried at fair value, they would be considered a Level 3 fair value measurement and would be determined based on the use of appraisals and input from market participants. Debt — The table below presents the estimated fair value of certain financial instruments not recorded at fair value on a recurring basis. The carrying amounts of the term loan approximates fair value. The term loan is classified as a Level 2 measurement according to the fair value hierarchy. The fair values of the senior unsecured notes are obtained from broker prices and are classified as Level 1 measurements according to the fair value hierarchy. July 31, 2021 October 31, 2020 Principal Amount Outstanding Fair Value Principal Amount Outstanding Fair Value 3-Year term loan, due March 2022 $ 925,000 $ 925,000 $ 925,000 $ 925,000 2.50% Senior unsecured notes, due December 2021 400,000 403,072 400,000 $ 408,565 2.875% Senior unsecured notes, due June 2023 500,000 523,041 500,000 $ 526,855 3.125% Senior unsecured notes, due December 2023 550,000 583,885 550,000 $ 590,177 2.95% Senior unsecured notes, due April 2025 400,000 429,643 400,000 $ 434,919 3.90% Senior unsecured notes, due December 2025 850,000 953,017 850,000 $ 969,033 3.50% Senior unsecured notes, due December 2026 900,000 1,004,709 900,000 $ 1,017,505 4.50% Senior unsecured notes, due December 2036 250,000 300,420 250,000 $ 298,153 5.30% Senior unsecured notes, due December 2045 400,000 549,646 400,000 $ 538,788 Total debt $ 5,175,000 $ 5,672,433 $ 5,175,000 $ 5,708,995 As of July 31, 2021, the Company believed that none of its unrealized losses on its available-for-sale investments were attributable to credit losses and therefore were not impaired. The investments with unrealized losses consisted primarily of corporate debt securities. In making the determination that the decline in fair value of these securities did not indicate impairment, the Company considered various factors, including, but not limited to: the extent to which fair value was less than cost; the financial condition and near-term prospects of the issuers; and the Company’s intent not to sell these securities and the assessment that it is more likely than not that the Company would not be required to sell these securities before the recovery of their amortized cost basis. Unrealized gains and losses, net of taxes, are reported as a component of AOCI in the Company’s Condensed Consolidated Statements of Stockholders’ Equity. No material amounts were reclassified out of AOCI during the three- and nine-month periods ended July 31, 2021 and August 1, 2020 for realized gains or losses on available-for-sale investments.

Derivatives

Derivatives	9 Months Ended
	Jul. 31, 2021
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivatives	Derivatives Foreign Exchange Exposure Management — The Company enters into forward foreign currency exchange contracts to offset certain operational and balance sheet exposures from the impact of changes in foreign currency exchange rates. Such exposures result from the portion of the Company’s operations, assets and liabilities that are denominated in currencies other than the U.S. dollar, primarily the Euro; other significant exposures include the British Pound, Philippine Peso and the Japanese Yen. Derivative instruments are employed to eliminate or minimize certain foreign currency exposures that can be confidently identified and quantified. These foreign currency exchange contracts are entered into to support transactions made in the normal course of business, and accordingly, are not speculative in nature. The contracts are for periods consistent with the terms of the underlying transactions, generally one year or less. Hedges related to anticipated transactions are matched with the underlying exposures at inception and designated and documented as cash flow hedges. They are qualitatively evaluated for effectiveness on a quarterly basis. The gain or loss on the derivative is recorded as a component of AOCI in shareholders’ equity and is reclassified into earnings in the same line item on the Consolidated Statements of Income as the impact of the hedged transaction in the same period during which the hedged transaction affects earnings. The total notional amounts of forward foreign currency derivative instruments designated as hedging instruments of cash flow hedges denominated in Euros, British Pounds, Philippine Pesos and Japanese Yen as of July 31, 2021 and October 31, 2020 were $236.5 million and $202.7 million, respectively. The fair values of forward foreign currency derivative instruments designated as hedging instruments in the Company’s Condensed Consolidated Balance Sheets as of July 31, 2021 and October 31, 2020 were as follows: Fair Value At Balance Sheet Location July 31, 2021 October 31, 2020 Forward foreign currency exchange contracts Prepaid expenses and other current assets $ — $ 5,550 Forward foreign currency exchange contracts Accrued liabilities $ 4,327 $ — As of July 31, 2021 and October 31, 2020, the total notional amounts of undesignated hedges related to forward foreign currency exchange contracts were $142.4 million and $62.7 million, respectively. The fair values of these hedging instruments in the Company’s Condensed Consolidated Balance Sheets were immaterial as of July 31, 2021 and October 31, 2020. The Company estimates $3.5 million, net of tax, of losses on forward foreign currency derivative instruments included in AOCI will be reclassified into earnings within the next twelve months. All of the Company’s derivative financial instruments are eligible for netting arrangements that allow the Company and its counterparties to net settle amounts owed to each other. Derivative assets and liabilities that can be net settled under these arrangements have been presented in the Company's Condensed Consolidated Balance Sheets on a net basis. As of July 31, 2021 and October 31, 2020, none of the netting arrangements involved collateral. The following table presents the gross amounts of the Company's forward foreign currency exchange contract derivative assets and liabilities and the net amounts recorded in the Company's Condensed Consolidated Balance Sheets: July 31, 2021 October 31, 2020 Gross amount of recognized assets $ 659 $ 6,114 Gross amounts of recognized liabilities (5,232) (687) Net (liabilities) assets offset and presented in the Condensed Consolidated Balance Sheets $ (4,573) $ 5,427 As of July 31, 2021 and October 31, 2020, the fair value of the interest rate swap agreement designated as a cash flow hedge was $181.2 million and $214.6 million, respectively, and is included within Accrued liabilities in the Company's Condensed Consolidated Balance Sheets. The market risk associated with the Company’s derivative instruments results from currency exchange rate or interest rate movements that are expected to offset the market risk of the underlying transactions, assets and liabilities being hedged. The counterparties to the agreements relating to the Company’s derivative instruments consist of a number of major international financial institutions with high credit ratings. Based on the credit ratings of the Company’s counterparties as of July 31, 2021 and October 31, 2020, nonperformance is not perceived to be a material risk. Furthermore, none of the Company’s derivatives are subject to collateral or other security arrangements and none contain provisions that are dependent on the Company’s credit ratings from any credit rating agency. While the contract or notional amounts of derivative financial instruments provide one measure of the volume of these transactions, they do not represent the amount of the Company’s exposure to credit risk. The amounts potentially subject to credit risk (arising from the possible inability of counterparties to meet the terms of their contracts) are generally limited to the amounts, if any, by which the counterparties’ obligations under the contracts exceed the obligations of the Company to the counterparties. As a result of the above considerations, the Company does not consider the risk of counterparty default to be significant. For information on the unrealized holding gains (losses) on derivatives included in and reclassified out of AOCI into the Condensed Consolidated Statements of Income related to forward foreign currency exchange contracts, see Note 3, Accumulated Other Comprehensive (Loss) Income, in these Notes to Condensed Consolidated Financial Statements for further information.

Inventories

Inventories	9 Months Ended
	Jul. 31, 2021
Inventory Disclosure [Abstract]
Inventories	Inventories Inventories at July 31, 2021 and October 31, 2020 were as follows: July 31, 2021 October 31, 2020 Raw materials $ 42,173 $ 33,806 Work in process 482,227 443,690 Finished goods 133,120 130,764 Total inventories $ 657,520 $ 608,260

Revolving Credit Facility

Revolving Credit Facility	9 Months Ended
	Jul. 31, 2021
Debt Disclosure [Abstract]
Revolving Credit Facility	Revolving Credit Facility On June 23, 2021, the Company entered into a Third Amended and Restated Credit Agreement (Revolving Credit Agreement) with Bank of America, N.A. as administrative agent and the other banks identified therein as lenders, which further amended and restated its existing Second Amended and Restated Credit Agreement dated as of June 28, 2019. The Revolving Credit Agreement provides for a five year unsecured revolving credit facility in an aggregate principal amount not to exceed (i) $1.25 billion or (ii) upon the completion of the acquisition by the Company of Maxim on or before January 12, 2022 (subject to certain terms and conditions), $2.5 billion. To date, the Company has not borrowed under this revolving credit facility but may borrow in the future and use the proceeds for repayment of existing indebtedness, stock repurchases, acquisitions, capital expenditures, working capital and other lawful corporate purposes. Revolving loans under the Revolving Credit Agreement can be Eurocurrency Rate Loans or Base Rate Loans (each as defined in the Revolving Credit Agreement) at the Company’s option. Each Eurocurrency Rate Loan will bear interest at a rate per annum equal to the applicable Eurocurrency Rate plus a margin based on the Company’s Debt Ratings (as defined in the Revolving Credit Agreement) from time to time of between 0.690% and 1.175%. Each Base Rate Loan will bear interest at a rate per annum equal to the Base Rate plus a margin based on the Company’s Debt Ratings from time to time of between 0.00% and 0.175%. In addition, the Company has agreed to pay a facility fee based on the Company’s Debt Ratings from time to time of between 0.060% and 0.200% multiplied by the actual daily amount of the Commitments (as defined in the Revolving Credit Agreement) in effect. The Revolving Credit Agreement also contains a sustainability-linked pricing component which provides for interest rate and facility fee reductions or increases based on the Company meeting or missing targets related to environmental sustainability, specifically greenhouse gas emissions and renewable energy usage. The Revolving Credit Agreement includes a multicurrency borrowing feature for certain specified foreign currencies. The Company will guarantee the obligations of each subsidiary that is named a Designated Borrower under the Revolving Credit Agreement. The Revolving Credit Agreement contains customary representations and warranties, and affirmative and negative covenants and events of default applicable to the Company and its subsidiaries. As of July 31, 2021, the Company was in compliance with these covenants.

Income Taxes

Income Taxes	9 Months Ended
	Jul. 31, 2021
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes The Company’s effective tax rates for the three- and nine-month periods ended July 31, 2021 and August 1, 2020 were below the U.S. statutory tax rate of 21.0%, due to lower statutory tax rates applicable to the Company's operations in the foreign jurisdictions in which it earns income. The Company has numerous audits ongoing throughout the world including: an IRS income tax audit for the fiscal year ended November 3, 2018 (fiscal 2018) and fiscal 2019; various U.S. state and local tax audits; and international audits. The Company's U.S. federal tax returns prior to the fiscal year ended October 28, 2017 (fiscal 2017) are no longer subject to examination. During the fourth quarter of fiscal 2018, the Company’s Irish tax resident subsidiary received an assessment, excluding any penalties and interest, for the fiscal year ended November 2, 2013 (fiscal 2013) of approximately €43.0 million, or approximately $51.0 million (as of July 31, 2021), from the Irish Revenue Commissioners (Irish Revenue). The assessment

New Accounting Pronouncements

New Accounting Pronouncements	9 Months Ended
	Jul. 31, 2021
Accounting Standards Update and Change in Accounting Principle [Abstract]
New Accounting Pronouncements	New Accounting Pronouncements Standards Implemented Financial Instruments In June 2016, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update 2016-13, Financial Instruments - Credit Losses (Topic 326), Measurement of Credit Losses on Financial Instruments (ASU 2016-13). ASU 2016-13 requires a financial asset (or group of financial assets) measured at amortized cost basis to be presented at the net amount expected to be collected. The allowance for credit losses is a valuation account that is deducted from the amortized cost basis of the financial asset(s) to present the net carrying value at the amount expected to be collected on the financial asset. In 2019, the FASB issued ASU 2019-05, Financial Instruments - Credit Losses (Topic 326): Targeted Transition Relief (ASU 2019-05) and ASU 2019-11, Codification Improvements to Topic 326 (ASU 2019-11). ASU 2019-05 allows an entity to irrevocably elect the fair value option for certain financial instruments. Once elected, an entity would recognize the difference between the carrying amount and the fair value of the financial instrument as part of the cumulative effect adjustments associated with the adoption of ASU 2016-13. ASU 2019-11 allows entities to exclude the accrued interest component of amortized cost from various disclosures required by ASC 326. The Company is exposed to credit losses through sales of its products and certain financial instruments. The Company determines if there is an expected loss on its accounts receivables using historical collection experience, current and future economic and market conditions and a review of the current status of customers' trade accounts receivables. The Company adopted these standards effective November 1, 2020 using the modified retrospective approach, which did not have a material impact on the Company's financial position and results of operations. See Note 8, Fair Value, in these Notes to Condensed Consolidated Financial Statements for more information related to how the Company assesses credit losses on its available-for-sale debt securities. Income taxes In December 2019, the FASB issued ASU 2019-12, Simplifying the Accounting for Income Taxes (ASU-2019-12). ASU 2019-12 eliminates certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. It also clarifies and simplifies other aspects of the accounting for income taxes. The Company adopted ASU 2019-12 in the first quarter of fiscal 2021. Upon adoption, ASU 2019-12 did not have a material impact on the Company's financial position and results of operations. Retirement Benefits In August 2018, the FASB issued ASU 2018-14, Compensation-Retirement Benefits-Defined Benefit Plans-General (Topic 715-20): Disclosure Framework-Changes to the Disclosure Requirements for Defined Benefit Plans (ASU 2018-14), which modifies the disclosure requirements for defined benefit pension plans and other post-retirement plans. ASU 2018-14 is effective for fiscal years ending after December 15, 2020, with early adoption permitted. The Company adopted ASU 2018-14 in the first quarter of fiscal 2021. Upon adoption, ASU 2018-14 did not have a material impact on the Company's financial position and results of operations. Standards to Be Implemented Reference Rate Reform In March 2020, the FASB issued ASU No. 2020-04, Reference Rate Reform (Topic 848) - Facilitation of the Effects of Reference Rate Reform on Financial Reporting , which provides optional guidance for accounting for contracts, hedging relationships, and other transactions affected by reference rate reform, if certain criteria are met. The provisions of this standard are available for election through December 31, 2022. The Company is currently evaluating the impact of the reference rate reform on its contracts and the resulting impact of adopting this standard on our financial statements.

Acquisitions

Acquisitions	9 Months Ended
	Jul. 31, 2021
Business Combinations [Abstract]
Acquisitions	Acquisitions Proposed Acquisition of Maxim Integrated Products, Inc. On July 12, 2020, the Company entered into the Merger Agreement to acquire Maxim, an independent manufacturer of innovative analog and mixed-signal products and technologies. Under the terms of the Merger Agreement, Maxim stockholders will receive, for each outstanding share of Maxim common stock, 0.630 of a share of the Company’s common stock at the closing. The estimated merger consideration is approximately $29.0 billion based on the closing price of the Company's common stock on August 13, 2021. The value of the merger consideration will fluctuate based upon changes in the price of the Company's common stock and the number of shares of Maxim common stock, restricted stock awards and restricted stock unit awards outstanding on the closing date. The transaction is subject to customary closing conditions, including receipt of regulatory approvals. To date, required regulatory approvals have been obtained in all jurisdictions with the exception of China. The Merger Agreement includes termination rights for both the Company and Maxim. The Company may be required to pay Maxim a regulatory termination fee of $830.0 million in cash if the Merger Agreement is terminated in certain circumstances involving the failure to obtain required regulatory approvals. On October 8, 2020, the required shareholder approvals relating to the Merger Agreement were obtained from both the Company's shareholders and Maxim's shareholders. In the three- and nine-month periods ended July 31, 2021, the Company incurred $18.3 million and $56.6 million of transaction-related costs related to the proposed acquisition of Maxim, respectively, recorded within Selling, marketing, general and administrative expenses in the Company's Condensed Consolidated Statements of Income.

Subsequent Events

Subsequent Events	9 Months Ended
	Jul. 31, 2021
Subsequent Events [Abstract]
Subsequent Events	Subsequent EventsOn August 17, 2021, the Board of Directors of the Company declared a cash dividend of $0.69 per outstanding share of common stock. The dividend will be paid on September 8, 2021 to all shareholders of record at the close of business on August 27, 2021 and is expected to total approximately $254.1 million.

Basis of Presentation (Policies

Basis of Presentation (Policies)	9 Months Ended
	Jul. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Fiscal Period	The Company has a 52-53 week fiscal year that ends on the Saturday closest to the last day in October. Certain amounts reported in previous periods have been reclassified to conform to the fiscal 2021 presentation.
Fair Value	The following methods and assumptions were used by the Company in estimating its fair value disclosures for financial instruments: Cash equivalents — These investments are adjusted to fair value based on quoted market prices or are determined using a yield curve model based on current market rates. Deferred compensation plan investments — The fair value of these mutual fund, money market fund and equity investments are based on quoted market prices. Interest rate derivatives — The fair value of the interest rate derivatives is estimated using a discounted cash flow analysis based on the contractual terms of the derivative. Forward foreign currency exchange contracts — The estimated fair value of forward foreign currency exchange contracts, which includes derivatives that are accounted for as cash flow hedges and those that are not designated as cash flow hedges, is based on the estimated amount the Company would receive if it sold these agreements at the reporting date taking into consideration current interest rates as well as the creditworthiness of the counterparty for assets and the Company’s creditworthiness for liabilities. The fair value of these instruments is based upon valuation models using current market information such as strike price, spot rate, maturity date and volatility.
Derivatives	Foreign Exchange Exposure Management — The Company enters into forward foreign currency exchange contracts to offset certain operational and balance sheet exposures from the impact of changes in foreign currency exchange rates. Such exposures result from the portion of the Company’s operations, assets and liabilities that are denominated in currencies other than the U.S. dollar, primarily the Euro; other significant exposures include the British Pound, Philippine Peso and the Japanese Yen. Derivative instruments are employed to eliminate or minimize certain foreign currency exposures that can be confidently identified and quantified. These foreign currency exchange contracts are entered into to support transactions made in the normal course of business, and accordingly, are not speculative in nature. The contracts are for periods consistent with the terms of the underlying transactions, generally one year or less. Hedges related to anticipated transactions are matched with the underlying exposures at inception and designated and documented as cash flow hedges. They are qualitatively evaluated for effectiveness on a quarterly basis. The gain or loss on the derivative is recorded as a component of AOCI in shareholders’ equity and is reclassified into earnings in the same line item on the Consolidated Statements of Income as the impact of the hedged transaction in the same period during which the hedged transaction affects earnings.
Standards Implemented and Standards to Be Implemented	Standards Implemented Financial Instruments In June 2016, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update 2016-13, Financial Instruments - Credit Losses (Topic 326), Measurement of Credit Losses on Financial Instruments (ASU 2016-13). ASU 2016-13 requires a financial asset (or group of financial assets) measured at amortized cost basis to be presented at the net amount expected to be collected. The allowance for credit losses is a valuation account that is deducted from the amortized cost basis of the financial asset(s) to present the net carrying value at the amount expected to be collected on the financial asset. In 2019, the FASB issued ASU 2019-05, Financial Instruments - Credit Losses (Topic 326): Targeted Transition Relief (ASU 2019-05) and ASU 2019-11, Codification Improvements to Topic 326 (ASU 2019-11). ASU 2019-05 allows an entity to irrevocably elect the fair value option for certain financial instruments. Once elected, an entity would recognize the difference between the carrying amount and the fair value of the financial instrument as part of the cumulative effect adjustments associated with the adoption of ASU 2016-13. ASU 2019-11 allows entities to exclude the accrued interest component of amortized cost from various disclosures required by ASC 326. The Company is exposed to credit losses through sales of its products and certain financial instruments. The Company determines if there is an expected loss on its accounts receivables using historical collection experience, current and future economic and market conditions and a review of the current status of customers' trade accounts receivables. The Company adopted these standards effective November 1, 2020 using the modified retrospective approach, which did not have a material impact on the Company's financial position and results of operations. See Note 8, Fair Value, in these Notes to Condensed Consolidated Financial Statements for more information related to how the Company assesses credit losses on its available-for-sale debt securities. Income taxes In December 2019, the FASB issued ASU 2019-12, Simplifying the Accounting for Income Taxes (ASU-2019-12). ASU 2019-12 eliminates certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. It also clarifies and simplifies other aspects of the accounting for income taxes. The Company adopted ASU 2019-12 in the first quarter of fiscal 2021. Upon adoption, ASU 2019-12 did not have a material impact on the Company's financial position and results of operations. Retirement Benefits In August 2018, the FASB issued ASU 2018-14, Compensation-Retirement Benefits-Defined Benefit Plans-General (Topic 715-20): Disclosure Framework-Changes to the Disclosure Requirements for Defined Benefit Plans (ASU 2018-14), which modifies the disclosure requirements for defined benefit pension plans and other post-retirement plans. ASU 2018-14 is effective for fiscal years ending after December 15, 2020, with early adoption permitted. The Company adopted ASU 2018-14 in the first quarter of fiscal 2021. Upon adoption, ASU 2018-14 did not have a material impact on the Company's financial position and results of operations. Standards to Be Implemented Reference Rate Reform In March 2020, the FASB issued ASU No. 2020-04, Reference Rate Reform (Topic 848) - Facilitation of the Effects of Reference Rate Reform on Financial Reporting , which provides optional guidance for accounting for contracts, hedging relationships, and other transactions affected by reference rate reform, if certain criteria are met. The provisions of this standard are available for election through December 31, 2022. The Company is currently evaluating the impact of the reference rate reform on its contracts and the resulting impact of adopting this standard on our financial statements.

Stock-Based Compensation and _2

Stock-Based Compensation and Shareholders' Equity (Tables)	9 Months Ended
	Jul. 31, 2021
Share-based Payment Arrangement [Abstract]
Summary of the activity under the company's stock option plans	A summary of the Company’s stock option activity as of July 31, 2021 and changes during the nine-month period then ended is presented below: Options Outstanding (in thousands) Weighted- Average Exercise Price Per Share Weighted- Average Remaining Contractual Term in Years Aggregate Intrinsic Value Options outstanding at October 31, 2020 4,192 $70.73 Options granted 644 $145.04 Options exercised (875) $63.18 Options forfeited (36) $87.18 Options expired (6) $40.69 Options outstanding at July 31, 2021 3,919 $84.53 5.7 $324,862 Options exercisable at July 31, 2021 2,511 $66.15 4.3 $254,262 Options vested or expected to vest at July 31, 2021 (1) 3,816 $83.41 5.7 $320,532 (1) In addition to the vested options, the Company expects a portion of the unvested options to vest at some point in the future. The number of options expected to vest is calculated by applying an estimated forfeiture rate to the unvested options.
Schedule of share-based compensation, restricted stock units award activity	A summary of the Company’s restricted stock unit/award activity as of July 31, 2021 and changes during the nine-month period then ended is presented below: Restricted Stock Units/Awards Outstanding (in thousands) Weighted- Average Grant- Date Fair Value Per Share Restricted stock units/awards outstanding at October 31, 2020 3,637 $91.54 Units/Awards granted 1,034 $143.88 Restrictions lapsed (1,160) $89.08 Forfeited (163) $100.74 Restricted stock units/awards outstanding at July 31, 2021 3,348 $107.70
Schedule of stock-based compensation expense	Total stock-based compensation expense recognized was as follows: Three Months Ended Nine Months Ended July 31, 2021 August 1, 2020 July 31, 2021 August 1, 2020 Cost of sales $ 4,331 $ 4,508 $ 13,338 $ 13,428 Research and development 19,806 19,158 57,675 55,163 Selling, marketing, general and administrative 17,550 14,951 47,670 43,427 Special charges, net — 943 — 943 Total stock-based compensation expense $ 41,687 $ 39,560 $ 118,683 $ 112,961

Accumulated Other Comprehensi_2

Accumulated Other Comprehensive (Loss) Income (Tables)	9 Months Ended
	Jul. 31, 2021
Equity [Abstract]
Components of accumulated other comprehensive loss, net of tax	The following table provides the changes in accumulated other comprehensive (loss) income (AOCI) by component and the related tax effects during the first nine months of fiscal 2021. Foreign currency translation adjustment Unrealized holding gains (losses) on derivatives Pension plans Total October 31, 2020 $ (26,852) $ (172,670) $ (49,939) $ (249,461) Other comprehensive income (loss) before reclassifications 5,073 32,548 (2,396) 35,225 Amounts reclassified out of other comprehensive income (loss) — (6,243) 2,245 (3,998) Tax effects — (6,452) (257) (6,709) Other comprehensive income (loss) 5,073 19,853 (408) 24,518 July 31, 2021 $ (21,779) $ (152,817) $ (50,347) $ (224,943)
Schedule of reclassification out of accumulated other comprehensive income	The amounts reclassified out of AOCI into the Condensed Consolidated Statements of Income and the Condensed Consolidated Statements of Shareholders' Equity with presentation location during each period were as follows: Three Months Ended Nine Months Ended Comprehensive Income Component July 31, 2021 August 1, 2020 July 31, 2021 August 1, 2020 Location Unrealized holding losses (gains) on derivatives Currency forwards $ (351) $ (842) $ (3,700) $ (762) Cost of sales (283) (226) (2,138) 640 Research and development 28 (189) (1,796) 895 Selling, marketing, general and administrative Interest rate derivatives 464 464 1,391 1,392 Interest expense (142) (793) (6,243) 2,165 Total before tax (28) 79 505 (488) Tax Effect of Accounting Standards Update 2018-02 — — — (2,379) Retained earnings $ (170) $ (714) $ (5,738) $ (702) Net of tax Amortization of pension components included in the computation of net periodic pension cost Actuarial losses 747 672 2,245 1,954 (85) (168) (257) (485) Tax $ 662 $ 504 $ 1,988 $ 1,469 Net of tax Total amounts reclassified out of AOCI, net of tax $ 492 $ (210) $ (3,750) $ 767

Earnings Per Share (Tables)

Earnings Per Share (Tables)	9 Months Ended
	Jul. 31, 2021
Earnings Per Share [Abstract]
Computation of basic and diluted earnings per share	The following table sets forth the computation of basic and diluted earnings per share: Three Months Ended Nine Months Ended July 31, 2021 August 1, 2020 July 31, 2021 August 1, 2020 Net Income $ 503,311 $ 362,665 $ 1,314,735 $ 834,235 Basic shares: Weighted-average shares outstanding 368,476 368,791 368,834 368,417 Earnings per common share basic: $ 1.37 $ 0.98 $ 3.56 $ 2.26 Diluted shares: Weighted-average shares outstanding 368,476 368,791 368,834 368,417 Assumed exercise of common stock equivalents 3,373 3,212 3,623 3,440 Weighted-average common and common equivalent shares 371,849 372,003 372,457 371,857 Earnings per common share diluted: $ 1.35 $ 0.97 $ 3.53 $ 2.24 Anti-dilutive shares related to: Outstanding stock-based awards 645 384 502 487

Special Charges, net (Tables)

Special Charges, net (Tables)	9 Months Ended
	Jul. 31, 2021
Restructuring and Related Activities [Abstract]
Schedule of accrued restructuring	The following table is a quarterly roll-forward from October 31, 2020 to July 31, 2021 of the employee separation and exit cost accruals established related to existing restructuring actions: Accrued Restructuring Closure of Manufacturing Facilities Repositioning Action Other Actions Balance at October 31, 2020 $ 45,176 $ 20,774 $ 3,489 First quarter fiscal 2021 special charges 438 — — Severance and other payments (1,950) (8,128) (333) Effect of foreign currency on accrual — 248 — Balance at January 30, 2021 $ 43,664 $ 12,894 $ 3,156 Second quarter fiscal 2021 special charges 311 — — Severance and other payments (5,769) (2,767) (270) Effect of foreign currency on accrual — (44) — Balance at May 1, 2021 $ 38,206 $ 10,083 $ 2,886 Third quarter fiscal 2021 special charges 4,618 — — Severance and other payments (15,949) (2,178) (219) Effect of foreign currency on accrual — (24) — Balance at July 31, 2021 $ 26,875 $ 7,881 $ 2,667 Accrued liabilities $ 26,875 $ 7,881 $ 2,667

Property, Plant and Equipment (

Property, Plant and Equipment (Tables)	9 Months Ended
	Jul. 31, 2021
Property, Plant and Equipment [Abstract]
Schedule of long lived assets held-for-sale	As shown below, this carrying value was reclassified from Property, plant and equipment to Prepaid expenses and other current assets upon designation and remains in Prepaid expenses and other current assets as of July 31, 2021. Land and buildings $ 42,608 Less accumulated depreciation and amortization (13,634) Net property, plant and equipment reclassified to Prepaid expenses and other current assets $ 28,974

Segment Information (Tables)

Segment Information (Tables)	9 Months Ended
	Jul. 31, 2021
Segment Reporting [Abstract]
Disaggregation of revenue	The following table summarizes revenue by end market. The categorization of revenue by end market is determined using a variety of data points including the technical characteristics of the product, the “sold to” customer information, the “ship to” customer information and the end customer product or application into which the Company’s product will be incorporated. As data systems for capturing and tracking this data and the Company's methodology evolves and improves, the categorization of products by end market can vary over time. When this occurs, the Company reclassifies revenue by end market for prior periods. Such reclassifications typically do not materially change the sizing of, or the underlying trends of results within, each end market. Three Months Ended July 31, 2021 August 1, 2020 Revenue % of Revenue* Y/Y% Revenue % of Revenue* Industrial $ 1,001,867 57 % 29 % $ 778,361 53 % Communications 288,743 16 % (21) % 363,304 25 % Automotive 290,077 16 % 80 % 161,489 11 % Consumer 178,166 10 % 16 % 152,982 11 % Total revenue $ 1,758,853 100 % 21 % $ 1,456,136 100 % Nine Months Ended July 31, 2021 August 1, 2020 Revenue % of Revenue* Y/Y% Revenue % of Revenue* Industrial $ 2,829,648 57 % 30 % $ 2,184,413 54 % Communications 847,632 17 % (4) % 880,633 22 % Automotive 793,443 16 % 45 % 548,002 13 % Consumer 507,995 10 % 10 % 463,713 11 % Total revenue $ 4,978,718 100 % 22 % $ 4,076,761 100 % * The sum of the individual percentages may not equal the total due to rounding. The following table summarizes revenue by channel. The Company sells its products globally through a direct sales force, third party distributors, independent sales representatives and via its website. Distributors are customers that buy products with the intention of reselling them. Direct customers are non-distributor customers and consist primarily of original equipment manufacturers (OEMs). Other customers include the U.S. government, government prime contractors and certain commercial customers for which revenue is recorded over time. Three Months Ended July 31, 2021 August 1, 2020 Channel Revenue % of Revenue* Revenue % of Revenue* Distributors $ 1,123,301 64 % $ 819,472 56 % Direct customers 588,001 33 % 614,770 42 % Other 47,551 3 % 21,894 2 % Total revenue $ 1,758,853 100 % $ 1,456,136 100 % Nine Months Ended July 31, 2021 August 1, 2020 Channel Revenue % of Revenue* Revenue % of Revenue* Distributors $ 3,162,615 64 % $ 2,317,421 57 % Direct customers 1,724,012 35 % 1,692,152 42 % Other 92,091 2 % 67,188 2 % Total revenue $ 4,978,718 100 % $ 4,076,761 100 % * The sum of the individual percentages may not equal the total due to rounding.

Fair Value (Tables)

Fair Value (Tables)	9 Months Ended
	Jul. 31, 2021
Fair Value Disclosures [Abstract]
Schedule of fair value of financial assets and liabilities	The tables below, set forth by level, presents the Company’s financial assets and liabilities, excluding accrued interest components that were accounted for at fair value on a recurring basis as of July 31, 2021 and October 31, 2020. The tables exclude cash on hand and assets and liabilities that are measured at historical cost or any basis other than fair value. As of July 31, 2021 and October 31, 2020, the Company held $289.7 million and $239.6 million, respectively, of cash that was excluded from the tables below. July 31, 2021 Fair Value measurement at Reporting Date using: Quoted Prices in Active Markets for Identical Assets (Level 1) Significant Other Observable Inputs (Level 2) Total Assets Cash equivalents: Available-for-sale: Government and institutional money market funds $ 810,935 $ — $ 810,935 Corporate obligations (1) — 380,050 380,050 Other assets: Deferred compensation plan investments 68,383 — 68,383 Total assets measured at fair value $ 879,318 $ 380,050 $ 1,259,368 Liabilities Forward foreign currency exchange contracts (2) $ — $ 4,573 $ 4,573 Interest rate derivatives — 181,189 181,189 Total liabilities measured at fair value $ — $ 185,762 $ 185,762 (1) The amortized cost of the Company’s investments classified as available-for-sale as of July 31, 2021 was $380.0 million. (2) The Company has master netting arrangements by counterparty with respect to derivative contracts. See Note 9, Derivatives, in these Notes to Condensed Consolidated Financial Statements for more information related to the Company's master netting arrangements. October 31, 2020 Fair Value measurement at Reporting Date using: Quoted Prices in Active Markets for Identical Assets (Level 1) Significant Other Observable Inputs (Level 2) Total Assets Cash equivalents: Available-for-sale: Government and institutional money market funds $ 816,253 $ — $ 816,253 Other assets: Forward foreign currency exchange contracts (1) — 5,427 5,427 Deferred compensation plan investments 52,956 — 52,956 Total assets measured at fair value $ 869,209 $ 5,427 $ 874,636 Liabilities Interest rate derivatives $ — $ 214,586 $ 214,586 Total liabilities measured at fair value $ — $ 214,586 $ 214,586 (1) The Company has master netting arrangements by counterparty with respect to derivative contracts. See Note 9, Derivatives, in these Notes to Condensed Consolidated Financial Statements for more information related to the Company's master netting arrangements.
Schedule of debt	The table below presents the estimated fair value of certain financial instruments not recorded at fair value on a recurring basis. The carrying amounts of the term loan approximates fair value. The term loan is classified as a Level 2 measurement according to the fair value hierarchy. The fair values of the senior unsecured notes are obtained from broker prices and are classified as Level 1 measurements according to the fair value hierarchy. July 31, 2021 October 31, 2020 Principal Amount Outstanding Fair Value Principal Amount Outstanding Fair Value 3-Year term loan, due March 2022 $ 925,000 $ 925,000 $ 925,000 $ 925,000 2.50% Senior unsecured notes, due December 2021 400,000 403,072 400,000 $ 408,565 2.875% Senior unsecured notes, due June 2023 500,000 523,041 500,000 $ 526,855 3.125% Senior unsecured notes, due December 2023 550,000 583,885 550,000 $ 590,177 2.95% Senior unsecured notes, due April 2025 400,000 429,643 400,000 $ 434,919 3.90% Senior unsecured notes, due December 2025 850,000 953,017 850,000 $ 969,033 3.50% Senior unsecured notes, due December 2026 900,000 1,004,709 900,000 $ 1,017,505 4.50% Senior unsecured notes, due December 2036 250,000 300,420 250,000 $ 298,153 5.30% Senior unsecured notes, due December 2045 400,000 549,646 400,000 $ 538,788 Total debt $ 5,175,000 $ 5,672,433 $ 5,175,000 $ 5,708,995

Derivatives (Tables)

Derivatives (Tables)	9 Months Ended
	Jul. 31, 2021
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of fair value of hedging instruments	The fair values of forward foreign currency derivative instruments designated as hedging instruments in the Company’s Condensed Consolidated Balance Sheets as of July 31, 2021 and October 31, 2020 were as follows: Fair Value At Balance Sheet Location July 31, 2021 October 31, 2020 Forward foreign currency exchange contracts Prepaid expenses and other current assets $ — $ 5,550 Forward foreign currency exchange contracts Accrued liabilities $ 4,327 $ —
Schedule of net amount of derivative assets and liabilities	The following table presents the gross amounts of the Company's forward foreign currency exchange contract derivative assets and liabilities and the net amounts recorded in the Company's Condensed Consolidated Balance Sheets: July 31, 2021 October 31, 2020 Gross amount of recognized assets $ 659 $ 6,114 Gross amounts of recognized liabilities (5,232) (687) Net (liabilities) assets offset and presented in the Condensed Consolidated Balance Sheets $ (4,573) $ 5,427

Inventories (Tables)

Inventories (Tables)	9 Months Ended
	Jul. 31, 2021
Inventory Disclosure [Abstract]
Schedule of inventories	Inventories at July 31, 2021 and October 31, 2020 were as follows: July 31, 2021 October 31, 2020 Raw materials $ 42,173 $ 33,806 Work in process 482,227 443,690 Finished goods 133,120 130,764 Total inventories $ 657,520 $ 608,260

Stock-Based Compensation and _3

Stock-Based Compensation and Shareholders' Equity - Outstanding Compensation (Details) $ / shares in Units, shares in Thousands, $ in Thousands	9 Months Ended
	Jul. 31, 2021USD ($)$ / sharesshares
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]
Options outstanding, at beginning of period (in shares) | shares	4,192
Options granted (in shares) | shares	644
Options exercised (in shares) | shares	(875)
Options forfeited (in shares) | shares	(36)
Options expired (in shares) | shares	(6)
Options outstanding, at end of period (in shares) | shares	3,919
Options exercisable (in shares) | shares	2,511
Options vested or expected to vest (in shares) | shares	3,816
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price
Options outstanding, weighted-average exercise price per share, at beginning of period (in dollars per share) | $ / shares	$ 70.73
Options granted, weighted-average exercise price per share (in dollars per share) | $ / shares	145.04
Options exercised, weighted-average exercise price per share (in dollars per share) | $ / shares	63.18
Options forfeited, weighted-average exercise price per share (in dollars per share) | $ / shares	87.18
Options expired, weighted-average exercise price per share (in dollars per share) | $ / shares	40.69
Options outstanding, weighted-average exercise price per share, at end of period (in dollars per share) | $ / shares	84.53
Options exercisable, weighted-average exercise price per share (in dollars per share) | $ / shares	66.15
Options vested or expected to vest, weighted-average exercise price per share (in dollars per share) | $ / shares	$ 83.41
Options outstanding, weighted-average remaining contractual term in years	5 years 8 months 12 days
Options exercisable, weighted-average remaining contractual term in years	4 years 3 months 18 days
Options vested or expected to vest, weighted-average remaining contractual term in years	5 years 8 months 12 days
Options outstanding, aggregate intrinsic value | $	$ 324,862
Options exercisable, aggregate intrinsic value | $	254,262
Options vested or expected to vest, aggregate intrinsic value | $	$ 320,532
Restricted Stock Units (RSUs)
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]
Restricted stock units/awards outstanding, at beginning of period (in shares) | shares	3,637
Units/Awards granted (in shares) | shares	1,034
Restrictions lapsed (in shares) | shares	(1,160)
Forfeited (in shares) | shares	(163)
Restricted stock units/awards outstanding, at end of period (in shares) | shares	3,348
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]
Restricted stock units/awards outstanding, at beginning of period (in dollar per shares) | $ / shares	$ 91.54
Units/Awards granted (in dollar per shares) | $ / shares	143.88
Restrictions lapsed (in dollar per shares) | $ / shares	89.08
Forfeited (in dollar per shares) | $ / shares	100.74
Restricted stock units/awards outstanding, at end of period (in dollar per shares) | $ / shares	$ 107.70

Stock-Based Compensation and _4

Stock-Based Compensation and Shareholders' Equity - Textual (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Millions	3 Months Ended	6 Months Ended	9 Months Ended
	Jan. 30, 2021	May 01, 2021	Jul. 31, 2021	Aug. 01, 2020	Oct. 31, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total intrinsic value of options exercised			$ 79.1	$ 61.7
Total unrecognized compensation cost related to unvested share-based awards, before tax consideration			$ 337.9
Weighted-average period to recognize compensation cost			1 year 4 months 24 days
Total grant-date fair value of vested stock options			$ 114.7	$ 157.9
Number of shares authorized to be repurchased (in shares)			159,000
Stock repurchase program, remaining authorized repurchase amount			$ 1,400
Inventories
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation			6		$ 5.8
Performance Stock Option
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares authorized (in shares)	460
Exercise price per share (in dollars per share)	$ 144.06
Award vesting period	5 years
Average closing price period	70 days
Maxim | Performance-based Restricted Stock Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period		2 years
Units granted (in shares)		121
Minimum | Performance Stock Option
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Target percentage	0.00%
Minimum | Maxim | Performance-based Restricted Stock Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Target percentage		0.00%
Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock repurchase program, authorized amount			$ 6,700
Maximum | Performance Stock Option
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Target percentage	100.00%
Maximum | Maxim | Performance-based Restricted Stock Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Target percentage		200.00%

Stock-Based Compensation and _5

Stock-Based Compensation and Shareholders' Equity - Stock-based Compensation Expense (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jul. 31, 2021	Aug. 01, 2020	Jul. 31, 2021	Aug. 01, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	$ 41,687	$ 39,560	$ 118,683	$ 112,961
Cost of sales
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	4,331	4,508	13,338	13,428
Research and development
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	19,806	19,158	57,675	55,163
Selling, marketing, general and administrative
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	17,550	14,951	47,670	43,427
Special charges, net
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	$ 0	$ 943	$ 0	$ 943

Accumulated Other Comprehensi_3

Accumulated Other Comprehensive (Loss) Income - Changes By Component and Tax Effect (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jul. 31, 2021	Aug. 01, 2020	Jul. 31, 2021	Aug. 01, 2020
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance			$ 11,997,945
Other comprehensive income (loss) before reclassifications			35,225
Amounts reclassified out of other comprehensive income (loss)			(3,998)
Tax effects			(6,709)
Other comprehensive (loss) income	$ (42,028)	$ 4,073	24,518	$ (82,751)
Ending balance	12,263,963		12,263,963
AOCI
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	(182,915)	(277,002)	(249,461)	(187,799)
Other comprehensive (loss) income	(42,028)	4,073	24,518	(82,751)
Ending balance	(224,943)	$ (272,929)	(224,943)	$ (272,929)
Foreign currency translation adjustment
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance			(26,852)
Other comprehensive income (loss) before reclassifications			5,073
Amounts reclassified out of other comprehensive income (loss)			0
Tax effects			0
Other comprehensive (loss) income			5,073
Ending balance	(21,779)		(21,779)
Unrealized holding gains (losses) on derivatives
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance			(172,670)
Other comprehensive income (loss) before reclassifications			32,548
Amounts reclassified out of other comprehensive income (loss)			(6,243)
Tax effects			(6,452)
Other comprehensive (loss) income			19,853
Ending balance	(152,817)		(152,817)
Pension plans
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance			(49,939)
Other comprehensive income (loss) before reclassifications			(2,396)
Amounts reclassified out of other comprehensive income (loss)			2,245
Tax effects			(257)
Other comprehensive (loss) income			(408)
Ending balance	$ (50,347)		$ (50,347)

Accumulated Other Comprehensi_4

Accumulated Other Comprehensive (Loss) Income - Amounts Reclassified Out of Accumulated Other Comprehensive (Loss) Income (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
	Jul. 31, 2021	Aug. 01, 2020	Jul. 31, 2021	Aug. 01, 2020	Nov. 02, 2019	May 01, 2021	Oct. 31, 2020	May 02, 2020
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Cost of sales	$ 537,669	$ 483,558	$ 1,575,526	$ 1,409,367
Research and development	306,617	260,794	897,005	770,280
Selling, marketing, general and administrative	206,076	153,753	597,963	494,808
Interest expense	44,659	45,914	130,204	144,712
Income before income taxes	572,278	373,029	1,484,881	894,307
Tax	(68,967)	(10,364)	(170,146)	(60,072)
Accounting standards update [extensible enumeration]					us-gaap:AccountingStandardsUpdate201802Member
Retained earnings	12,263,963		12,263,963				$ 11,997,945
Net income	503,311	362,665	1,314,735	834,235
Unrealized holding gains (losses) on derivatives
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Retained earnings	(152,817)		(152,817)				(172,670)
Retained earnings
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Retained earnings	7,812,859	7,079,309	7,812,859	7,079,309	$ 6,899,253	$ 7,564,054	7,236,238	$ 6,945,442
Net income	503,311	362,665	1,314,735	834,235
Retained earnings | Cumulative effect, period of adoption, adjustment
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Retained earnings					$ 2,379
Pension plans
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Retained earnings	(50,347)		(50,347)				$ (49,939)
Reclassification out of Accumulated Other Comprehensive Income
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Net income	492	(210)	(3,750)	767
Reclassification out of Accumulated Other Comprehensive Income | Unrealized holding gains (losses) on derivatives
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Income before income taxes	(142)	(793)	(6,243)	2,165
Tax	(28)	79	505	(488)
Net income	(170)	(714)	(5,738)	(702)
Reclassification out of Accumulated Other Comprehensive Income | Retained earnings | Cumulative effect, period of adoption, adjustment
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Retained earnings	0	(2,379)	0	(2,379)
Reclassification out of Accumulated Other Comprehensive Income | Pension plans
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Income before income taxes	747	672	2,245	1,954
Tax	(85)	(168)	(257)	(485)
Net income	662	504	1,988	1,469
Reclassification out of Accumulated Other Comprehensive Income | Currency forwards | Unrealized holding gains (losses) on derivatives
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Cost of sales	(351)	(842)	(3,700)	(762)
Research and development	(283)	(226)	(2,138)	640
Selling, marketing, general and administrative	28	(189)	(1,796)	895
Reclassification out of Accumulated Other Comprehensive Income | Interest rate derivatives | Unrealized holding gains (losses) on derivatives
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Interest expense	$ 464	$ 464	$ 1,391	$ 1,392

Earnings Per Share (Details)

Earnings Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Jul. 31, 2021	Aug. 01, 2020	Jul. 31, 2021	Aug. 01, 2020
Earnings per share
Net Income	$ 503,311	$ 362,665	$ 1,314,735	$ 834,235
Basic shares:
Weighted-average shares outstanding (in shares)	368,476	368,791	368,834	368,417
Earnings per common share, basic (in dollars per share)	$ 1.37	$ 0.98	$ 3.56	$ 2.26
Diluted shares:
Weighted-average shares outstanding (in shares)	368,476	368,791	368,834	368,417
Assumed exercise of common stock equivalents (in shares)	3,373	3,212	3,623	3,440
Weighted-average common and common equivalent shares (in shares)	371,849	372,003	372,457	371,857
Earnings per common share, diluted (in dollars per share)	$ 1.35	$ 0.97	$ 3.53	$ 2.24
Anti-dilutive shares related to:
Outstanding share-based awards (in shares)	645	384	502	487

Special Charges, net - Restruct

Special Charges, net - Restructuring (Details) - USD ($) $ in Thousands	3 Months Ended				9 Months Ended
	Jul. 31, 2021	May 01, 2021	Jan. 30, 2021	Aug. 01, 2020	Jul. 31, 2021	Aug. 01, 2020
Summary of the Company's special charges and accruals related to ongoing actions, Balance Sheet
Special charges, net	$ (8,938)			$ 31,830	$ (8,189)	$ 44,286
Closure of Manufacturing Facilities
Summary of the Company's special charges and accruals related to ongoing actions, Balance Sheet
Accrued restructuring, beginning balance	38,206	$ 43,664	$ 45,176		45,176
Special charges, net	4,618	311	438
Severance and other payments	(15,949)	(5,769)	(1,950)
Effect of foreign currency on accrual	0	0	0
Accrued restructuring, ending balance	26,875	38,206	43,664		26,875
Closure of Manufacturing Facilities | Accrued liabilities
Summary of the Company's special charges and accruals related to ongoing actions, Balance Sheet
Accrued restructuring, ending balance	26,875				26,875
Repositioning Action
Summary of the Company's special charges and accruals related to ongoing actions, Balance Sheet
Accrued restructuring, beginning balance	10,083	12,894	20,774		20,774
Special charges, net	0	0	0
Severance and other payments	(2,178)	(2,767)	(8,128)
Effect of foreign currency on accrual	(24)	(44)	248
Accrued restructuring, ending balance	7,881	10,083	12,894		7,881
Repositioning Action | Accrued liabilities
Summary of the Company's special charges and accruals related to ongoing actions, Balance Sheet
Accrued restructuring, ending balance	7,881				7,881
Other Actions
Summary of the Company's special charges and accruals related to ongoing actions, Balance Sheet
Accrued restructuring, beginning balance	2,886	3,156	3,489		3,489
Special charges, net	0	0	0
Severance and other payments	(219)	(270)	(333)
Effect of foreign currency on accrual	0	0	0
Accrued restructuring, ending balance	2,667	$ 2,886	$ 3,156		2,667
Other Actions | Accrued liabilities
Summary of the Company's special charges and accruals related to ongoing actions, Balance Sheet
Accrued restructuring, ending balance	$ 2,667				$ 2,667

Special Charges, net - Textual

Special Charges, net - Textual (Details) - USD ($) $ in Thousands	3 Months Ended				9 Months Ended		12 Months Ended
	Jul. 31, 2021	May 01, 2021	Jan. 30, 2021	Aug. 01, 2020	Jul. 31, 2021	Aug. 01, 2020	Nov. 02, 2019
Restructuring Cost and Reserve [Line Items]
Special charges, net	$ (8,938)			$ 31,830	$ (8,189)	$ 44,286
Gain on sale of property, plant and equipment					13,557	$ 0
Singapore | Discontinued Operations, Disposed of by Sale | Testing Facility
Restructuring Cost and Reserve [Line Items]
Gain on sale of property, plant and equipment	13,600
Singapore | Discontinued Operations, Held-for-sale or Disposed of by Sale | Testing Facility
Restructuring Cost and Reserve [Line Items]
Consideration from sale of facility	35,700				35,700
Closure of Manufacturing Facilities
Restructuring Cost and Reserve [Line Items]
Special charges, net	4,618	$ 311	$ 438
Closure of Manufacturing Facilities | Linear Technology Corporation
Restructuring Cost and Reserve [Line Items]
Special charges, cumulative	46,800				46,800
Repositioning Action
Restructuring Cost and Reserve [Line Items]
Special charges, net	0	$ 0	$ 0
Special charges, cumulative	137,500				137,500
Repositioning Action | Intellectual Property
Restructuring Cost and Reserve [Line Items]
Impairment of intangible assets, finite-lived							$ 14,200
Severance and Fringe Benefits
Restructuring Cost and Reserve [Line Items]
Special charges, cumulative	$ 123,300				$ 123,300

Property, Plant and Equipment -

Property, Plant and Equipment - Reclassification (Details) $ in Thousands	Jul. 31, 2021USD ($)
Long Lived Assets Held-for-sale [Line Items]
Less accumulated depreciation and amortization	$ (13,634)
Net property, plant and equipment reclassified to Prepaid expenses and other current assets	28,974
Land and buildings
Long Lived Assets Held-for-sale [Line Items]
Property, plant and equipment, gross	$ 42,608

Segment Information - Textual (

Segment Information - Textual (Details)	9 Months Ended
	Jul. 31, 2021segment
Segment Reporting [Abstract]
Number of reportable segments	1
Number of operating segments	9

Segment Information - Revenue T

Segment Information - Revenue Trends by Segment (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jul. 31, 2021	Aug. 01, 2020	Jul. 31, 2021	Aug. 01, 2020
Revenue Trends
Revenue	$ 1,758,853	$ 1,456,136	$ 4,978,718	$ 4,076,761
Percent of Revenue (as percent)	100.00%	100.00%	100.00%	100.00%
Year over Year Change (as percent)	21.00%		22.00%
Industrial
Revenue Trends
Revenue	$ 1,001,867	$ 778,361	$ 2,829,648	$ 2,184,413
Percent of Revenue (as percent)	57.00%	53.00%	57.00%	54.00%
Year over Year Change (as percent)	29.00%		30.00%
Communications
Revenue Trends
Revenue	$ 288,743	$ 363,304	$ 847,632	$ 880,633
Percent of Revenue (as percent)	16.00%	25.00%	17.00%	22.00%
Year over Year Change (as percent)	(21.00%)		(4.00%)
Automotive
Revenue Trends
Revenue	$ 290,077	$ 161,489	$ 793,443	$ 548,002
Percent of Revenue (as percent)	16.00%	11.00%	16.00%	13.00%
Year over Year Change (as percent)	80.00%		45.00%
Consumer
Revenue Trends
Revenue	$ 178,166	$ 152,982	$ 507,995	$ 463,713
Percent of Revenue (as percent)	10.00%	11.00%	10.00%	11.00%
Year over Year Change (as percent)	16.00%		10.00%

Segment Information - Revenue b

Segment Information - Revenue by Sales Channel (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jul. 31, 2021	Aug. 01, 2020	Jul. 31, 2021	Aug. 01, 2020
Segment Reporting Information [Line Items]
Revenue	$ 1,758,853	$ 1,456,136	$ 4,978,718	$ 4,076,761
Percent of Revenue (as percent)	100.00%	100.00%	100.00%	100.00%
Distributors
Segment Reporting Information [Line Items]
Revenue	$ 1,123,301	$ 819,472	$ 3,162,615	$ 2,317,421
Percent of Revenue (as percent)	64.00%	56.00%	64.00%	57.00%
Direct customers
Segment Reporting Information [Line Items]
Revenue	$ 588,001	$ 614,770	$ 1,724,012	$ 1,692,152
Percent of Revenue (as percent)	33.00%	42.00%	35.00%	42.00%
Other
Segment Reporting Information [Line Items]
Revenue	$ 47,551	$ 21,894	$ 92,091	$ 67,188
Percent of Revenue (as percent)	3.00%	2.00%	2.00%	2.00%

Fair Value - Textual (Details)

Fair Value - Textual (Details) - USD ($) $ in Millions	Jul. 31, 2021	Oct. 31, 2020
Fair Value Disclosures [Abstract]
Cash	$ 289.7	$ 239.6

Fair Value - Assets and Liabili

Fair Value - Assets and Liabilities (Details) - USD ($) $ in Thousands	Jul. 31, 2021	Oct. 31, 2020
Liabilities
Amortized cost	$ 380,000
Recurring
Other assets:
Forward foreign currency exchange contracts		$ 5,427
Deferred compensation plan investments	68,383	52,956
Total assets measured at fair value	1,259,368	874,636
Liabilities
Forward foreign currency exchange contracts	4,573
Interest rate derivatives	181,189	214,586
Total liabilities measured at fair value	185,762	214,586
Recurring | Government and institutional money market funds
Available-for-sale:
Cash equivalents available for sale	810,935	816,253
Recurring | Corporate obligations
Available-for-sale:
Cash equivalents available for sale	380,050
Recurring | Level 1
Other assets:
Forward foreign currency exchange contracts		0
Deferred compensation plan investments	68,383	52,956
Total assets measured at fair value	879,318	869,209
Liabilities
Forward foreign currency exchange contracts	0
Interest rate derivatives	0	0
Total liabilities measured at fair value	0	0
Recurring | Level 1 | Government and institutional money market funds
Available-for-sale:
Cash equivalents available for sale	810,935	816,253
Recurring | Level 1 | Corporate obligations
Available-for-sale:
Cash equivalents available for sale	0
Recurring | Level 2
Other assets:
Forward foreign currency exchange contracts		5,427
Deferred compensation plan investments	0	0
Total assets measured at fair value	380,050	5,427
Liabilities
Forward foreign currency exchange contracts	4,573
Interest rate derivatives	181,189	214,586
Total liabilities measured at fair value	185,762	214,586
Recurring | Level 2 | Government and institutional money market funds
Available-for-sale:
Cash equivalents available for sale	0	$ 0
Recurring | Level 2 | Corporate obligations
Available-for-sale:
Cash equivalents available for sale	$ 380,050

Fair Value - Debt (Details)

Fair Value - Debt (Details) - USD ($)	9 Months Ended
	Jul. 31, 2021	Oct. 31, 2020
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Principal Amount Outstanding	$ 5,175,000,000	$ 5,175,000,000
Fair Value	$ 5,672,433,000	5,708,995,000
3-Year term loan, due March 2022 | Unsecured debt term
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt term	3 years
Principal Amount Outstanding	$ 925,000,000	925,000,000
Fair Value	$ 925,000,000	925,000,000
2.50% Senior unsecured notes, due December 2021 | Senior Notes
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Interest rate	2.50%
Principal Amount Outstanding	$ 400,000,000	400,000,000
Fair Value	$ 403,072,000	408,565,000
2.875% Senior unsecured notes, due June 2023 | Senior Notes
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Interest rate	2.875%
Principal Amount Outstanding	$ 500,000,000	500,000,000
Fair Value	$ 523,041,000	526,855,000
3.125% Senior unsecured notes, due December 2023 | Senior Notes
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Interest rate	3.125%
Principal Amount Outstanding	$ 550,000,000	550,000,000
Fair Value	$ 583,885,000	590,177,000
2.95% Senior unsecured notes, due April 2025 | Senior Notes
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Interest rate	2.95%
Principal Amount Outstanding	$ 400,000,000	400,000,000
Fair Value	$ 429,643,000	434,919,000
3.90% Senior unsecured notes, due December 2025 | Senior Notes
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Interest rate	3.90%
Principal Amount Outstanding	$ 850,000,000	850,000,000
Fair Value	$ 953,017,000	969,033,000
3.50% Senior unsecured notes, due December 2026 | Senior Notes
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Interest rate	3.50%
Principal Amount Outstanding	$ 900,000,000	900,000,000
Fair Value	$ 1,004,709,000	1,017,505,000
4.50% Senior unsecured notes, due December 2036 | Senior Notes
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Interest rate	4.50%
Principal Amount Outstanding	$ 250,000,000	250,000,000
Fair Value	$ 300,420,000	298,153,000
5.30% Senior unsecured notes, due December 2045 | Senior Notes
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Interest rate	5.30%
Principal Amount Outstanding	$ 400,000,000	400,000,000
Fair Value	$ 549,646,000	$ 538,788,000

Derivatives - Textual (Details)

Derivatives - Textual (Details) - USD ($) $ in Thousands	9 Months Ended
	Jul. 31, 2021	Oct. 31, 2020
Derivative [Line Items]
Contracts period	1 year
Derivative assets, fair value	$ 659	$ 6,114
Forward Contracts
Derivative [Line Items]
Notional amount of cash flow hedges	236,500	202,700
Notional amount of derivative	142,400	62,700
Cash flow hedge gain (loss) to be reclassified within twelve months	3,500
Interest Rate Swap Agreements | Accrued liabilities | Designated as Hedging Instrument
Derivative [Line Items]
Derivative assets, fair value	$ 181,200	$ 214,600

Derivatives - Forward Foreign C

Derivatives - Forward Foreign Currency (Details) - Forward foreign currency exchange contracts - USD ($) $ in Thousands	Jul. 31, 2021	Oct. 31, 2020
Prepaid expenses and other current assets
Derivatives, Fair Value [Line Items]
Foreign currency contracts, liability	$ 0	$ 5,550
Accrued liabilities
Derivatives, Fair Value [Line Items]
Foreign currency contracts, liability	$ 4,327	$ 0

Derivative - Net Amounts (Detai

Derivative - Net Amounts (Details) - USD ($) $ in Thousands	Jul. 31, 2021	Oct. 31, 2020
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Gross amount of recognized assets	$ 659	$ 6,114
Gross amounts of recognized liabilities	(5,232)	(687)
Net (liabilities) assets offset and presented in the Condensed Consolidated Balance Sheets	$ (4,573)
Net (liabilities) assets offset and presented in the Condensed Consolidated Balance Sheets		$ 5,427

Inventories (Details)

Inventories (Details) - USD ($) $ in Thousands	Jul. 31, 2021	Oct. 31, 2020
Inventory Disclosure [Abstract]
Raw materials	$ 42,173	$ 33,806
Work in process	482,227	443,690
Finished goods	133,120	130,764
Total inventories	$ 657,520	$ 608,260

Revolving Credit Facility (Deta

Revolving Credit Facility (Details) - Revolving credit facility - Unsecured debt term - USD ($)	Jun. 23, 2021	Jul. 31, 2021
Line of Credit Facility [Line Items]
Debt term	5 years
Amount available under credit facility	$ 1,250,000,000
Maxim
Line of Credit Facility [Line Items]
Amount available under credit facility	$ 2,500,000,000
Minimum
Line of Credit Facility [Line Items]
Line of credit facility, commitment fee percentage		0.06%
Minimum | Eurodollar
Line of Credit Facility [Line Items]
Debt instrument, basis spread on variable rate		0.69%
Minimum | Fed Funds Effective Rate Overnight Index Swap Rate
Line of Credit Facility [Line Items]
Debt instrument, basis spread on variable rate		0.00%
Maximum
Line of Credit Facility [Line Items]
Line of credit facility, commitment fee percentage		0.20%
Maximum | Eurodollar
Line of Credit Facility [Line Items]
Debt instrument, basis spread on variable rate		1.175%
Maximum | Fed Funds Effective Rate Overnight Index Swap Rate
Line of Credit Facility [Line Items]
Debt instrument, basis spread on variable rate		0.175%

Income Taxes (Details)

Income Taxes (Details) € in Millions, $ in Millions	3 Months Ended		9 Months Ended
	Jul. 31, 2021EUR (€)	Aug. 01, 2020	Jul. 31, 2021EUR (€)	Aug. 01, 2020	Jul. 31, 2021USD ($)
Income Tax Contingency [Line Items]
Federal statutory rate (as percent)	21.00%	21.00%	21.00%	21.00%
Revenue Commissioners, Ireland | Fiscal year 2013
Income Tax Contingency [Line Items]
Income tax examination, excluding penalties and interest expense	€ 43		€ 43		$ 51

Acquisitions (Details)

Acquisitions (Details) - Maxim $ in Millions	Aug. 13, 2021USD ($)	Jul. 31, 2021USD ($)	Jul. 31, 2021USD ($)	Jul. 12, 2020USD ($)
Business Acquisition [Line Items]
Conversion of company common stock				0.630
Termination fee, regulatory clearance				$ 830
Subsequent event
Business Acquisition [Line Items]
Consideration transferred	$ 29,000
Selling, marketing, general and administrative
Business Acquisition [Line Items]
Transaction related costs		$ 18.3	$ 56.6

Subsequent Events (Details)

Subsequent Events (Details) - Common Stock - Subsequent event $ / shares in Units, $ in Millions	Aug. 17, 2021USD ($)$ / shares
Subsequent Event [Line Items]
Common stock cash dividends per share, declared (in dollars per share) | $ / shares	$ 0.69
Dividends | $	$ 254.1